跳至主要内容
临床试验/2022-502890-40-00
2022-502890-40-00招募中3 期

FIRE Stones : Impact of Furosemide on the residual fragment rate after flexible ureteroscopy for destruction of kidney stones with laser : a controlled two-parallel group multicenter trial with blinding evaluation

Centre Hospitalier Regional Universitaire De Tours9 个研究点 分布在 1 个国家目标入组 374 人开始时间: 2023年9月27日最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
374
试验地点
9
主要终点
Stone-free rate at 3 months of a flexible ureteroscopy for renal stone laser destruction, evaluated on the low dose abdomino-pelvic CT-Scan. A centralized review of the images will be performed by two specialized radiologists, in a blind and crossed way to allow a homogenization of the results

研究概览

简要总结

To show that the injection of 40 mg of Furosemide in slow intravenous during 10 minutes after the procedure, increases the stone-free rate 3 months after a flexible ureteroscopy for destruction of kidney stones with laser.

研究设计

分配方式
Not Applicable
主要目的
Follow-up
盲法
None

入排标准

年龄范围
18 years 至 65+ years(65+ Years, 18-64 Years)
接受健康志愿者

入选标准

  • Male or female ≥ 18 years old < 80 years old
  • With the need to perform a flexible ureteroscopy with destruction of the kidney stones with laser
  • Person affiliated to a French social security system or equivalent
  • Written informed consent obtained from the participant
  • Ability for participant to comply with the requirements of the study
  • Stones of less than 3 cm

排除标准

  • Contra-indication to Furosemide: o Hyper-sensitivity to the active substance or one of the excipients o Hyper-sensitivity to Sulfonamide o Renal failure with oligo-anuria refractory to Furosemide o Hypokalemia < 3,5 mmol/L o Severe hyponatremia o Hypovolemia with or without hypotension or dehydration o Ongoing hepatitis, hepatic insufficiency severe and hepatic encephalopathy
  • Patient having Furosemide as usual treatment
  • Patient requiring an injection of Aminoside or Vancomycin before or during the procedure
  • Participation in other interventional research with an investigational drug or medical device
  • Persons covered by articles L1121-5 to L1121-8 of the CSP (corresponding to all protected persons: pregnant women, parturients, nursing mothers, persons deprived of their liberty by judicial or administrative decision, minors, and persons subject to a legal protection measure: guardianship or trusteeship)
  • Hepatic insufficiency due to the risk of hepatic encephalopathy
  • Hepatorenal syndrome
  • Hypoproteinemia especially in case of nephrotic syndrome
  • Drug-drug interactions with furosemide especially the lithium

结局指标

主要结局

Stone-free rate at 3 months of a flexible ureteroscopy for renal stone laser destruction, evaluated on the low dose abdomino-pelvic CT-Scan. A centralized review of the images will be performed by two specialized radiologists, in a blind and crossed way to allow a homogenization of the results

Stone-free rate at 3 months of a flexible ureteroscopy for renal stone laser destruction, evaluated on the low dose abdomino-pelvic CT-Scan. A centralized review of the images will be performed by two specialized radiologists, in a blind and crossed way to allow a homogenization of the results

次要结局

  • Post-operative urinary tract infection will be assessed within 30 days after surgery on the combination of: - Fever higher than 38.5°C and/or, - Chills and/or, - Clinical symptoms (supra-pubic pain, dysuria, pollakiuria, urgency, urinary burning, back pain radiating to the genitals, hematuria) and/or - Positive urine culture with a significant bacteriuria threshold.
  • Post-operative pain will be assessed using a numerical pain scale ranging from 0 to 10 in the recovery room, in the service and at the discharge.
  • Furosemide adverse events will be assessed.
  • Effect of the prescription of an alpha-blocker will be looked at considering the primary outcome
  • Evaluation of agreement between the imaging analysis of the urologist and the specialized radiologist will be looked at considering the primary outcome. Urologists will assess CT-Scan while the study is going on while specialized radiologists will assess the CT Scan at the end of the study.

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

LETOUCHE Marie-Lou

Scientific

Centre Hospitalier Regional Universitaire De Tours

研究点 (9)

Loading locations...

相似试验

FIRE Stones : Impact of Furosemide on the residual... | 临床试验